BridgeBio Pharma (BBIO) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1
-0.74
-0.47
-0.2

Details

Expected EPS
-1.003318
Actual EPS
-0.86
Surprise EPS
0.14
Surprise Percent
+14.28%

Description

⁨BridgeBio Pharma⁩ (⁦BBIO⁩) has reported earnings of ⁦-0.86⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts